Share this article on:

Predicting the Severity of Clostridium Difficile Infection

Wilcox, Mark H. MD, BMedSci, BM, BS, MRCPath

Infectious Diseases in Clinical Practice: September 2011 - Volume 19 - Issue 5 - p 305-306
doi: 10.1097/IPC.0b013e318230961a
Editorial Comment

From the Department of Microbiology, Leeds Teaching Hospitals NHS Trust; Old Medical School, Leeds General Infirmary; and Leeds Institute of Molecular Medicine, University of Leeds, Leeds, UK.

Correspondence to: Mark H. Wilcox, MD, BMedSci, BMBS, Microbiology, Old Medical School, Leeds General Infirmary, Leeds LS1 3EX, W Yorks, UK. E-mail: mark.wilcox@leedsth.nhs.uk.

Prof. Wilcox has received honoraria for consultancy work, financial support to attend meetings, and research funding from Actelion, Genzyme, Leo Laboratories, Novacta, Optimer, Pfizer, and The Medicines Company.

© 2011 Lippincott Williams & Wilkins, Inc.